Family Planning Market Report
As the family planning (FP) community continues to face funding challenges and uncertainty, the future of the FP commodity market may be under threat. Analysis from the recently published 2017 Family Planning Market Report has revealed a sharp market value decline of 28 percent from 2015 to 2016 in the public and social sectors of the 69 FP2020 focus countries, after remaining relatively stable since 2011. The report – jointly produced by the Clinton Health Access Initiative and the Reproductive Health Supplies Coalition – suggests that the value decrease was caused by a substantial decline in shipment volumes particularly among injectables and oral contraceptive pills (combined and progestin only) and was not attributed to any pricing changes. While the shift towards long-acting methods driven by the growth of implants helped offset some of the declines in implied couple years of protection shipped, it is still the lowest the market has seen in six years. Further, the donor-funded market, analyzed as a subset of the public and social sector market, has seen a corresponding decline in donor-funded shipments from 2015 to 2016.